IR-Med (IR-Med) Net Change in Cash : $-2.69 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is IR-Med Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

IR-Med's Net Change in Cash for the three months ended in Mar. 2024 was $-0.36 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.69 Mil.

IR-Med Net Change in Cash Historical Data

The historical data trend for IR-Med's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR-Med Net Change in Cash Chart

IR-Med Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

1.63

0.95

0.19

-2.24

IR-Med Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial										-0.90	-0.77	-0.81	-0.75	-0.36

IR-Med Net Change in Cash Calculation

IR-Med's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-3.232	+	-0.002	+	1	+	-0.001
	=	-2.24

IR-Med's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.358 + 0 + 0 + -0.001

= -0.36

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IR-Med Net Change in Cash Related Terms
Thank you for viewing the detailed overview of IR-Med's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

IR-Med (IR-Med) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IR-Med Inc (OTCPK:IRME) » Definitions » Net Change in Cash

Comparable Companies

CATX XAIR RBOT CTSO SGHT RTGN NSPR NVNO CUTR APYX ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA

Traded in Other Exchanges

N/A

Address

Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400

Website

https://www.ir-medical.com

IR-Med Inc is a medical device company that specializes in infrared-based technologies. It develops medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies.

IR-Med (IR-Med) Headlines

From GuruFocus

IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device
By sperokesalga sperokesalga • 06-07-2023

IR-Med Announces Dr. David Dalton as Advisory Board member
By Value_Insider Value_Insider • 11-16-2022

IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device
By Ds*** Ds*** • 08-30-2022

IR-Med To Initiate Useability Study of its PressureSafe Device
By GuruFocusNews GuruFocusNews • 06-23-2022

IR-MED's AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care
By Marketwired • 07-17-2023

IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries
By sperokesalga sperokesalga • 06-12-2023

IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024
By Marketwired • 09-26-2023

IR-Med To Initiate Useability Study of its PressureSafe Device
By GuruFocusNews GuruFocusNews • 07-03-2022

IR-MED Appoints Richard Serbin, Esq. to its Advisory Board
By Marketwired • 09-13-2023

IR-Med's PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health's 10th Annual Shining the Light on Wound Care Symposium
By sperokesalga sperokesalga • 05-19-2023